Trials / Completed
CompletedNCT03777917
A Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow
Pilot Study to Assess the Effectiveness and Safety of Belotero Balance® Injection for Volume Augmentation of the Infraorbital Hollow
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The pilot study aims to define safety, effectiveness, and patient-reported outcomes for Belotero Balance® use in the infraorbital hollows.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Belotero Balance® | Belotero® Balance for infraorbital hollows. Mode of application: subdermal injection. |
Timeline
- Start date
- 2018-12-27
- Primary completion
- 2019-06-18
- Completion
- 2020-03-11
- First posted
- 2018-12-17
- Last updated
- 2023-11-14
- Results posted
- 2022-09-02
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03777917. Inclusion in this directory is not an endorsement.